CA2028261C - Non-invasive method and apparatus for measuring blood glucose concentration - Google Patents
Non-invasive method and apparatus for measuring blood glucose concentrationInfo
- Publication number
- CA2028261C CA2028261C CA002028261A CA2028261A CA2028261C CA 2028261 C CA2028261 C CA 2028261C CA 002028261 A CA002028261 A CA 002028261A CA 2028261 A CA2028261 A CA 2028261A CA 2028261 C CA2028261 C CA 2028261C
- Authority
- CA
- Canada
- Prior art keywords
- laser diode
- glucose concentration
- blood glucose
- blood
- light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Emergency Medicine (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
ABSTRACT OF THE INVENTION
A method and apparatus for measuring blood glucose concentration by irraditing blood vessels with electromagnetic radiation using near-infrared radiation diffuse-reflection laser spectroscopy. This invention uses electromagnetic radiation of a wavelength that is transmitted through the skin to the measurement part, for example, a blood vessel. Since skin is mostly composed of water (H2O), which absorbs IR radiation in nearly the entire IR spectral range, only radiation of a certain, narrow protion of the IR spectral range called the "water transmission window" is transmitted through the skin. The present invention uses electromagnetic radiation with a wavelength of 1.3µm?1.9µm radiation from a semiconductor diode laser.
When electromagnetic radiation of these wavelengths irradiates the skin, light is transmitted through the skin to the blood vessel where the light interacts with the heterogeneous components of the blood. The light which reaches the blood is then diffusely reflected by the blood. The reflected light will have been modulated by the characteristic vibrations of the molecules which are major components of blood. The reflected light is detected and provided as a digital signal to a one-chip microcomputer. The one-chip microcomputer calculates a blood glucose concentration from the digital signal by reference to a calibration curve stored in the memory of the one-chip microcomputer. The one-chip microcomputer causes the calculated blood glucose concentration to be displayed on a digital display.
A method and apparatus for measuring blood glucose concentration by irraditing blood vessels with electromagnetic radiation using near-infrared radiation diffuse-reflection laser spectroscopy. This invention uses electromagnetic radiation of a wavelength that is transmitted through the skin to the measurement part, for example, a blood vessel. Since skin is mostly composed of water (H2O), which absorbs IR radiation in nearly the entire IR spectral range, only radiation of a certain, narrow protion of the IR spectral range called the "water transmission window" is transmitted through the skin. The present invention uses electromagnetic radiation with a wavelength of 1.3µm?1.9µm radiation from a semiconductor diode laser.
When electromagnetic radiation of these wavelengths irradiates the skin, light is transmitted through the skin to the blood vessel where the light interacts with the heterogeneous components of the blood. The light which reaches the blood is then diffusely reflected by the blood. The reflected light will have been modulated by the characteristic vibrations of the molecules which are major components of blood. The reflected light is detected and provided as a digital signal to a one-chip microcomputer. The one-chip microcomputer calculates a blood glucose concentration from the digital signal by reference to a calibration curve stored in the memory of the one-chip microcomputer. The one-chip microcomputer causes the calculated blood glucose concentration to be displayed on a digital display.
Description
2~2~
BACIGROUND OF T~ INVENTIO~
FI~LD OF THL INV~NTIOR
The present invention relates to a aethod and apparatus for aeasuring blood glucose concentration, and ~ore particularly, to a non-invasive technique for aeasuring blood glucose concentration using near-infrared radiation diffuse-reflection laser spectroscopy.
PRIOR ART
Generally, diabetics ~easure blood glucose concentration t~o to eight ti~es daily using a portable neasure-ent apparatus consisting of an injector (to obtain a blood saaple) and test Paper (to easure the a ount of gluco~e in the blood). This is known as the "enzyaatic" ethod or test.
The enzy~atic test for glucose concentration is undesirable both because it requires that blood be drawn and because it iB expensive. Less expensive techniques based on test paper have been introduced, but they are less accurate and still require that blood be drawn. Accordingly, research has been conducted to addres~ these proble~s.
It is desired to provide a ~ethod for neasuring blood glucose concentration that is accurate and does not require the drawing oi blood.
~ ~ ;
2~2~2~
.
Therefore, it is an object of the present invention i~ to provide a non-invasive technique for easuring blood glucose concentration, that is, to eliainate the need for drawing blood ior this aeasure~ent A further object o~ the present invention i8 to provide a convenient, - inexpensive, portable, easy-to-use apparatus ior aeasuring blood glucose concentration .~ , '' : ' ', :~' ' ' ~ ~ ' . ' ' 2~ 26~
~UH~ARY OF THE INVE~TION
The present invention i8 based on near-in~rared radiation diffuse-reflection laser spectroscopy which Deasures blood gluco~e concentration by irradiating blood ves6els with haraless electroaagnetic radiation This invention uses electroaagnetic radiation of a vavelength that is transnitted through the skin to the aeasureaent part, for exa Ple, a blood vessel Since skin is nostly conposed of water (HzO), which absorbs IR
radiation in nearlY the entire IR spectral range, only radiation of a certain, narrow portion of the IR spectral range called the "water trans~ission window" will be transnitted through the s~in Until recently, the water transaission window was thouRth to only include wavelengths between 3~ 5~ However, according to investigations by the present inventors, the wavelength which is able to reach a blood vessel through the water transnission window includes wavelenBths between 1 3~ 1 9~
Accordingly, the present invention uses electronagnetic radiation with a wavelength of 1 3~ 1 9~ radiation froe a seniconductor diode laser When electronagnetic radiation of these wavelengths irradates the skin, ligth is trans~itted through the 6kin to the blood vessel where the light interacts with the heterogeneous co~ponents of the blood The light which reaches the blood is then diffuselY reflected by the blood The reflected light will ... . , - .............. ,: , ... .
: ,, :. . ;, ,:, . ,::
. .
2 ~
have been nodulated by the characteristic vibrations of the nolecules ~hich are aior co~ponents of blood In the present invention, the diffusely reflected light described above is integrated by an integrating sphere The photons (hv) integrated as described above, are converted into an electrical neasureaent value by a detector, and that vlaue is supplied to a processing eans, such as a one-chip ~icroco~puter The one-chip nicrocoaputer calculates the blood glucose concentration using an accurate calibration aethod Near-infrared radiation is de~ined in the present invention (in accordance ~ith the International Union of Pure and Applied Che-istry (IUPAC) definition) as follows; frequency of about 10l8~ 3 75x lOl~Hz; energy of about 0 951~ 35 8(Rcal/-ol), 0 0412~ 1 55eV; wavelength oi about 0 8~ 30y The present invention is based on phYsical and chevical principles describing the vibrational aotion of the blood glucose ~olecules as easured with near-infrared radiation diffuse-reflection laser spectroscoPy Such vibrational notion includes both rotational and translational otion, and includes overtone vibrations and co-bination vibrations Of these vibrations, the overtone vibrations are do-inant The analysis nethod incorporated in the Present invention includes a satheuatical eodel based on nultiPle linear regression analysis and ~ultivariate analysis as ~odified by the Present inventor~ to deter-in~ the blood glucose concentration t ,', ~, " ':' ' ' , 2 ~ 6 ~
The present invention provides a nethod and apparatus for e~fiurin~
blood glucose concentration, which has the advantage oi ease oi u~e and ainiaal expense for patients The present invention ha~ no consu able parts and is portable, allowing easy out-oi-hooe testing The present invention is aore convenient than the prior art techniques Also, this invention does not present the possible physical daaa8e associated with the long-tern use of syringes The easurenent apparatus of the present invention can easure blood glucose concentration in a short tiae and unobtrusively Thereiore, the prior art techniques, with their inconvenience and expense are rendered obsolete The object and other objects oi the present invention are achieved by neasuring blood glucose concentration in a non-invasive technique, where .
a Power source, for exanple, a battery is supplied to a one-chip nicro-conputer, a digtal display, a laser diode pover supply, a detector (as needed), and an optical unit (as needed) by aeans of a power switch The one-chip icroco~puter controls the laser diode power supply so that it gradually applies current at a stable voltage and tenperature to the laser diode, which eaits the neces6ary wavelengths oi radiation bY aeans of a start/reset switch The one-chip eicroconputer i8 operated so that the D/A
converter controlled by said one-chip vicroco-puter and driving said laser dioed power supply converts a digital control signal into an analog control '., '. : ~ , ' ; " ' '`, ; ;' ~
2 ~ 1 signal.
Thus, the laser diode power supply causes the laser diode to eoit a wavelength suitable for neasurement. The light fron said laser diode iB
colli~ated, or otherNise optically controlled, separated and conbined. The optically controlled light is used to irradiate the skin adjacent to a blood vessel. ~he light absorbed, dispersed and diffusely re~lected by the blood back throu~h the skin is integrated by an inteBrating sphere. The photons collected by the integratinB sphere are converted into an analog electrical signal with a detector. The analog electrical signal is trans~itted to a preanplifier where the analog electrical signal is amplified. The aupli~ied analog electrical signal is provided to an analog to digital (A/D) converter that converts the anplified analog electrical signal to a corresPonding digital signal and outputs the digital signal to a one-chip uicrocomPuter.
The one-chip microcomputer calculates a blood glucose concentration ~rom the digital signal by reference to a calibration curve ~tored in the ~enorY of the one~chip ~icrocomputer. The one-chiP ~icroconputer causes the calculated blood glucose concentration to be disPlaYed on a di~ital display.
An apparatus for easuriDg blood glucose concentration using a non-invasive technique according to the present invention comprises:
one-chip oicrocomputer which controls the laser diode power supply so that current is gradually applied to a laser diode at a stable voltage and te~perature. The one- chip ~icrocomputer calculates the blood glucose concentration by co~paring a detected value with a calibration curve stroed . .. . . , , , ., . :
~; ,-- ::. . , , : ~
. : . .. .. . .
.. . .. .
.,, : .
~2~'2611 in aeaory of the one-chip icrocoaputer A D/A converter converts the digital control signal output fron said one-chip microconputer into an analog control signal for control of the laser diode power supply that supplies power to the laser diode The laser diode is a light source for the blood glucose concentration ~easure-ent There ~ay be a pluralitY of laser diodes for emitting light of different wavelengths or for eaitting light of like wavelengths in accordance with the current supplied froa the laser diode power supply A teoperature controller for controlling the teuperature of the laser diode is connected bet~een the laser diode po~er supply and the laser diode An optical unit colliaates the light enitted fron the laser diode, or opticallY controls, separates and co bines the light fron the laser diode An integrating sphere integrates the light dispersed and difiusely reilected iroa the blood ~hen the blood is illuainated throu8h the skin by light froa the optical unit A detector for converts the photons collected by the intergrating sphere into an analog electrical value ~hich is then a-plified in the preasplifie~ An A/D
converter converts the electrical analog aeasurenent value into a digital value A digital disPlaY dispalys the blood glucose concentration calculated by the one-chip aicroco~puter : ~. . - .. . .: ~ . ;; .
.. ...
., . : : . - ~ ; . :~
2~2~
BRIEF DESCRIPTION OF THF DRAWING$
These and other objects and features of ths present invention will be understood through the various enbodi~ents by reference to the acconpanying drawings in which Figure 1 is a block diagran showing an apparatus for neasuring blood glucose concentration according to the present invention; and Figure 2 is a detailed circuit diagraa showing the apparatu~ for Figure 1.
. - ~ : - . : i ; .
, ,; . , ~ :
, ~02~261 DETAIL~D DESCRIPTION OF T~E IN~ENTION
A preferred eabodi~ent of a ~easureaent apparatus according to the present invention will be described hereinafter with reference to the acco-panying drawings Referring to Pigure 1, when a power BWitCh 1 iB switched oa. a power i8 supplied fron the battery (generally 4 5~ 9~ and i8 suited to a charging battery of 6V aaong other possibilities) to a one-chiP wicrocoePUter 2 At the sa-e tine, the power source iB aupplied to a digital displaY 3, a laser diode power supplY 4, and optical unit ~ (as needed) If the start/reset sNitch 8 is then switched ON, the laser diode power supply 4 supplies the laser diode 5 with power in accordance ~ith the control signal supplied by the one-chip icroconputer 2 AB a result, the laser diode current gradually increases if the current exceeds the threshold current (approxiDately 20aA) Thus, laser diode 5 starts e~itting light The laser diode 5 enits light (for exauple, light having a wavelength of 1 3~a~ 1 9~, and light having a wavelenBth of 1 4~e~ 1 8~s, aaong others), of a wavelength necessary for blood glucose concentration eacure~ent This wavelength iB achieved by gradually increasinB the current supplied with in the range of approxiaatelY 20~ 200~A at a stable voltage and te~perature in accordance with the characteristics of the laser diode In the present .:.: , . .. . .
, ~; . . .:, .,: .
. ., . . ~ . , . , : , -. ; ~. ~.. :,: :
... ..
2~26~
invention, the laser diode 5 is coaposed of between 1 and 30 diodes, and each nay enit light of a diiferent ~avelength, or each ~ay e-it light of the sane wavelength The light enitted froa the collective diodes in the la~er diode ~ naY be si-ultaneously e-itted by the diodes or 6equentially eaitted by each diode In case of sinultaneous operation, length ~ill be selected, for exa ple, using the ~ourier Transforn The light outputted frou the collective diodes oi the laser diode 5 i~
supplied to an optical unit 8, and colliaated, or the light is optically controlled, separated and coebined Thereafter, the light is pa~sed through an integrating sphere 9 and divided in one or eore directions The light which Pas~es through the integrating sphere 9 i~ successively irradiated to the skin of a subject, or is successively irradiated to a reierence port which ~as ready beforehand as the case nay be Here, the .
~ reference port i6 not necessarily needed , . .
The light absorbed, dispersed and diffusely reflected froa the blood is detected by a detector 7 after being integrated bY neans of the integrating sphere 9 The integrating 6phere i8 of a globular or like shape Here, the size of integrating sphere 9, ~hich i6 integrated ~ith light dispersed and reflected frou the blood, has a ~idth, length and height under 2 56CR, and is ~uitable for under 1 28cn, and nore Particularly~ is suitable for under . . : ........ . ~ ...... ,.- .: ..... ..
- . . . . ~ , .: - : ,.,.~ .'::: i :
-: 2~2~
0 64c~
An electrical analog aeasureaent value detected as above described is a-plified by a prea plifier connected to the detector 7 Thereafter, the electrical analoB neasureaent value is converted into a digital easurenent value by aeans of an A/D converter 11 Next, the one-chiP uicrocoaputer 2 calcolates and coaputes the neasured value by coaparing the signal converted into a digital neasureaent value by the A/D converter 11 with a calibration curve stored in aeaory of the one-chip icroco puter 2 The resultant value i8 difiplayed on the digital display 3 The di-ension~ of the above-described aeasureaent apparatus waY be widthx lengthxheight under 170nnX80H X 25n , and is suitable for under lS0~aX 75-nx 22 , a ong others, and aore particularly, is suitable for under 130- x70- x 20na "
A photo diode is suitable as the detector 7 aod aay be a 6e detector, and aore particularly, nay be a Ge detector connected to a preaaplifier Horeover, the optical unit 6 i9 co~posed of conponents which constitute a light which has a diaueter under 0 5N 5~r (under 2ee aaong others) in order to condense and diffuse the light in parallel ~urthereore, the present invention is not li-ited to an inteBrating - : .: :: ,. . . ~ .: :
2~26 ~
sphere 9 having a globular or li~e shape, but it aay also be o~ an oval or a half-oval or dii~erent shape In the present invention, the port ean be separated fron the above neasureaent apparatus In this case, the light euitted froa the laser diode 5 can be transnitted to the port through the optie ~iber, and the distanee between the port and the neasureaent apparatus is 100~ 1,OOO~e and is suitable for 500~ aaong others, and nore Partieularly, aay be 300 0 course, the port cannot be separated fro- the easureaent apparatu6 The present invention is not li-ited for one-chiP ieroeoaputer 2 separated froa the D/A converter 10 and the A/D converter 11, but can also be a one-chip ieroco puter 2 which is included in the D/A eonverter ln and the A/D eonverter 11 ,.~
Moreover, in the present invention, it ean be u~ed with au~iliary eireuit 12 which is conposed of RAM 12l and EPROM 12z in order to aid an operation of one-ehip ieroco-puter 2 ` .
The present invention is not li-ited for the easure-ent of blood glueose eoncentration and, for exanple, can be applied to a neasurenent of a cholesterol concentration or an alcohol concentration According to the Present invention as above described, there is Provided an econo~ic cethod and apparatus for easuring blood glucose concentration ::: , : :.
-. : ., ~ : ..... ~ : . ..
: ~ .: ,.... . . ..
,, ~, . . . -2~2~'26~
in a non-invasive technique, which can easily aeasure the blood d ucose concentration by putting port of the apParatus to a certain part of the hu an bodY sight of a blood ve~sel without using an equip ent, such as a conventional iniector.
,, . - .,: . . .
BACIGROUND OF T~ INVENTIO~
FI~LD OF THL INV~NTIOR
The present invention relates to a aethod and apparatus for aeasuring blood glucose concentration, and ~ore particularly, to a non-invasive technique for aeasuring blood glucose concentration using near-infrared radiation diffuse-reflection laser spectroscopy.
PRIOR ART
Generally, diabetics ~easure blood glucose concentration t~o to eight ti~es daily using a portable neasure-ent apparatus consisting of an injector (to obtain a blood saaple) and test Paper (to easure the a ount of gluco~e in the blood). This is known as the "enzyaatic" ethod or test.
The enzy~atic test for glucose concentration is undesirable both because it requires that blood be drawn and because it iB expensive. Less expensive techniques based on test paper have been introduced, but they are less accurate and still require that blood be drawn. Accordingly, research has been conducted to addres~ these proble~s.
It is desired to provide a ~ethod for neasuring blood glucose concentration that is accurate and does not require the drawing oi blood.
~ ~ ;
2~2~2~
.
Therefore, it is an object of the present invention i~ to provide a non-invasive technique for easuring blood glucose concentration, that is, to eliainate the need for drawing blood ior this aeasure~ent A further object o~ the present invention i8 to provide a convenient, - inexpensive, portable, easy-to-use apparatus ior aeasuring blood glucose concentration .~ , '' : ' ', :~' ' ' ~ ~ ' . ' ' 2~ 26~
~UH~ARY OF THE INVE~TION
The present invention i8 based on near-in~rared radiation diffuse-reflection laser spectroscopy which Deasures blood gluco~e concentration by irradiating blood ves6els with haraless electroaagnetic radiation This invention uses electroaagnetic radiation of a vavelength that is transnitted through the skin to the aeasureaent part, for exa Ple, a blood vessel Since skin is nostly conposed of water (HzO), which absorbs IR
radiation in nearlY the entire IR spectral range, only radiation of a certain, narrow portion of the IR spectral range called the "water trans~ission window" will be transnitted through the s~in Until recently, the water transaission window was thouRth to only include wavelengths between 3~ 5~ However, according to investigations by the present inventors, the wavelength which is able to reach a blood vessel through the water transnission window includes wavelenBths between 1 3~ 1 9~
Accordingly, the present invention uses electronagnetic radiation with a wavelength of 1 3~ 1 9~ radiation froe a seniconductor diode laser When electronagnetic radiation of these wavelengths irradates the skin, ligth is trans~itted through the 6kin to the blood vessel where the light interacts with the heterogeneous co~ponents of the blood The light which reaches the blood is then diffuselY reflected by the blood The reflected light will ... . , - .............. ,: , ... .
: ,, :. . ;, ,:, . ,::
. .
2 ~
have been nodulated by the characteristic vibrations of the nolecules ~hich are aior co~ponents of blood In the present invention, the diffusely reflected light described above is integrated by an integrating sphere The photons (hv) integrated as described above, are converted into an electrical neasureaent value by a detector, and that vlaue is supplied to a processing eans, such as a one-chip ~icroco~puter The one-chip nicrocoaputer calculates the blood glucose concentration using an accurate calibration aethod Near-infrared radiation is de~ined in the present invention (in accordance ~ith the International Union of Pure and Applied Che-istry (IUPAC) definition) as follows; frequency of about 10l8~ 3 75x lOl~Hz; energy of about 0 951~ 35 8(Rcal/-ol), 0 0412~ 1 55eV; wavelength oi about 0 8~ 30y The present invention is based on phYsical and chevical principles describing the vibrational aotion of the blood glucose ~olecules as easured with near-infrared radiation diffuse-reflection laser spectroscoPy Such vibrational notion includes both rotational and translational otion, and includes overtone vibrations and co-bination vibrations Of these vibrations, the overtone vibrations are do-inant The analysis nethod incorporated in the Present invention includes a satheuatical eodel based on nultiPle linear regression analysis and ~ultivariate analysis as ~odified by the Present inventor~ to deter-in~ the blood glucose concentration t ,', ~, " ':' ' ' , 2 ~ 6 ~
The present invention provides a nethod and apparatus for e~fiurin~
blood glucose concentration, which has the advantage oi ease oi u~e and ainiaal expense for patients The present invention ha~ no consu able parts and is portable, allowing easy out-oi-hooe testing The present invention is aore convenient than the prior art techniques Also, this invention does not present the possible physical daaa8e associated with the long-tern use of syringes The easurenent apparatus of the present invention can easure blood glucose concentration in a short tiae and unobtrusively Thereiore, the prior art techniques, with their inconvenience and expense are rendered obsolete The object and other objects oi the present invention are achieved by neasuring blood glucose concentration in a non-invasive technique, where .
a Power source, for exanple, a battery is supplied to a one-chip nicro-conputer, a digtal display, a laser diode pover supply, a detector (as needed), and an optical unit (as needed) by aeans of a power switch The one-chip icroco~puter controls the laser diode power supply so that it gradually applies current at a stable voltage and tenperature to the laser diode, which eaits the neces6ary wavelengths oi radiation bY aeans of a start/reset switch The one-chip eicroconputer i8 operated so that the D/A
converter controlled by said one-chip vicroco-puter and driving said laser dioed power supply converts a digital control signal into an analog control '., '. : ~ , ' ; " ' '`, ; ;' ~
2 ~ 1 signal.
Thus, the laser diode power supply causes the laser diode to eoit a wavelength suitable for neasurement. The light fron said laser diode iB
colli~ated, or otherNise optically controlled, separated and conbined. The optically controlled light is used to irradiate the skin adjacent to a blood vessel. ~he light absorbed, dispersed and diffusely re~lected by the blood back throu~h the skin is integrated by an inteBrating sphere. The photons collected by the integratinB sphere are converted into an analog electrical signal with a detector. The analog electrical signal is trans~itted to a preanplifier where the analog electrical signal is amplified. The aupli~ied analog electrical signal is provided to an analog to digital (A/D) converter that converts the anplified analog electrical signal to a corresPonding digital signal and outputs the digital signal to a one-chip uicrocomPuter.
The one-chip microcomputer calculates a blood glucose concentration ~rom the digital signal by reference to a calibration curve ~tored in the ~enorY of the one~chip ~icrocomputer. The one-chiP ~icroconputer causes the calculated blood glucose concentration to be disPlaYed on a di~ital display.
An apparatus for easuriDg blood glucose concentration using a non-invasive technique according to the present invention comprises:
one-chip oicrocomputer which controls the laser diode power supply so that current is gradually applied to a laser diode at a stable voltage and te~perature. The one- chip ~icrocomputer calculates the blood glucose concentration by co~paring a detected value with a calibration curve stroed . .. . . , , , ., . :
~; ,-- ::. . , , : ~
. : . .. .. . .
.. . .. .
.,, : .
~2~'2611 in aeaory of the one-chip icrocoaputer A D/A converter converts the digital control signal output fron said one-chip microconputer into an analog control signal for control of the laser diode power supply that supplies power to the laser diode The laser diode is a light source for the blood glucose concentration ~easure-ent There ~ay be a pluralitY of laser diodes for emitting light of different wavelengths or for eaitting light of like wavelengths in accordance with the current supplied froa the laser diode power supply A teoperature controller for controlling the teuperature of the laser diode is connected bet~een the laser diode po~er supply and the laser diode An optical unit colliaates the light enitted fron the laser diode, or opticallY controls, separates and co bines the light fron the laser diode An integrating sphere integrates the light dispersed and difiusely reilected iroa the blood ~hen the blood is illuainated throu8h the skin by light froa the optical unit A detector for converts the photons collected by the intergrating sphere into an analog electrical value ~hich is then a-plified in the preasplifie~ An A/D
converter converts the electrical analog aeasurenent value into a digital value A digital disPlaY dispalys the blood glucose concentration calculated by the one-chip aicroco~puter : ~. . - .. . .: ~ . ;; .
.. ...
., . : : . - ~ ; . :~
2~2~
BRIEF DESCRIPTION OF THF DRAWING$
These and other objects and features of ths present invention will be understood through the various enbodi~ents by reference to the acconpanying drawings in which Figure 1 is a block diagran showing an apparatus for neasuring blood glucose concentration according to the present invention; and Figure 2 is a detailed circuit diagraa showing the apparatu~ for Figure 1.
. - ~ : - . : i ; .
, ,; . , ~ :
, ~02~261 DETAIL~D DESCRIPTION OF T~E IN~ENTION
A preferred eabodi~ent of a ~easureaent apparatus according to the present invention will be described hereinafter with reference to the acco-panying drawings Referring to Pigure 1, when a power BWitCh 1 iB switched oa. a power i8 supplied fron the battery (generally 4 5~ 9~ and i8 suited to a charging battery of 6V aaong other possibilities) to a one-chiP wicrocoePUter 2 At the sa-e tine, the power source iB aupplied to a digital displaY 3, a laser diode power supplY 4, and optical unit ~ (as needed) If the start/reset sNitch 8 is then switched ON, the laser diode power supply 4 supplies the laser diode 5 with power in accordance ~ith the control signal supplied by the one-chip icroconputer 2 AB a result, the laser diode current gradually increases if the current exceeds the threshold current (approxiDately 20aA) Thus, laser diode 5 starts e~itting light The laser diode 5 enits light (for exauple, light having a wavelength of 1 3~a~ 1 9~, and light having a wavelenBth of 1 4~e~ 1 8~s, aaong others), of a wavelength necessary for blood glucose concentration eacure~ent This wavelength iB achieved by gradually increasinB the current supplied with in the range of approxiaatelY 20~ 200~A at a stable voltage and te~perature in accordance with the characteristics of the laser diode In the present .:.: , . .. . .
, ~; . . .:, .,: .
. ., . . ~ . , . , : , -. ; ~. ~.. :,: :
... ..
2~26~
invention, the laser diode 5 is coaposed of between 1 and 30 diodes, and each nay enit light of a diiferent ~avelength, or each ~ay e-it light of the sane wavelength The light enitted froa the collective diodes in the la~er diode ~ naY be si-ultaneously e-itted by the diodes or 6equentially eaitted by each diode In case of sinultaneous operation, length ~ill be selected, for exa ple, using the ~ourier Transforn The light outputted frou the collective diodes oi the laser diode 5 i~
supplied to an optical unit 8, and colliaated, or the light is optically controlled, separated and coebined Thereafter, the light is pa~sed through an integrating sphere 9 and divided in one or eore directions The light which Pas~es through the integrating sphere 9 i~ successively irradiated to the skin of a subject, or is successively irradiated to a reierence port which ~as ready beforehand as the case nay be Here, the .
~ reference port i6 not necessarily needed , . .
The light absorbed, dispersed and diffusely reflected froa the blood is detected by a detector 7 after being integrated bY neans of the integrating sphere 9 The integrating 6phere i8 of a globular or like shape Here, the size of integrating sphere 9, ~hich i6 integrated ~ith light dispersed and reflected frou the blood, has a ~idth, length and height under 2 56CR, and is ~uitable for under 1 28cn, and nore Particularly~ is suitable for under . . : ........ . ~ ...... ,.- .: ..... ..
- . . . . ~ , .: - : ,.,.~ .'::: i :
-: 2~2~
0 64c~
An electrical analog aeasureaent value detected as above described is a-plified by a prea plifier connected to the detector 7 Thereafter, the electrical analoB neasureaent value is converted into a digital easurenent value by aeans of an A/D converter 11 Next, the one-chiP uicrocoaputer 2 calcolates and coaputes the neasured value by coaparing the signal converted into a digital neasureaent value by the A/D converter 11 with a calibration curve stored in aeaory of the one-chip icroco puter 2 The resultant value i8 difiplayed on the digital display 3 The di-ension~ of the above-described aeasureaent apparatus waY be widthx lengthxheight under 170nnX80H X 25n , and is suitable for under lS0~aX 75-nx 22 , a ong others, and aore particularly, is suitable for under 130- x70- x 20na "
A photo diode is suitable as the detector 7 aod aay be a 6e detector, and aore particularly, nay be a Ge detector connected to a preaaplifier Horeover, the optical unit 6 i9 co~posed of conponents which constitute a light which has a diaueter under 0 5N 5~r (under 2ee aaong others) in order to condense and diffuse the light in parallel ~urthereore, the present invention is not li-ited to an inteBrating - : .: :: ,. . . ~ .: :
2~26 ~
sphere 9 having a globular or li~e shape, but it aay also be o~ an oval or a half-oval or dii~erent shape In the present invention, the port ean be separated fron the above neasureaent apparatus In this case, the light euitted froa the laser diode 5 can be transnitted to the port through the optie ~iber, and the distanee between the port and the neasureaent apparatus is 100~ 1,OOO~e and is suitable for 500~ aaong others, and nore Partieularly, aay be 300 0 course, the port cannot be separated fro- the easureaent apparatu6 The present invention is not li-ited for one-chiP ieroeoaputer 2 separated froa the D/A converter 10 and the A/D converter 11, but can also be a one-chip ieroco puter 2 which is included in the D/A eonverter ln and the A/D eonverter 11 ,.~
Moreover, in the present invention, it ean be u~ed with au~iliary eireuit 12 which is conposed of RAM 12l and EPROM 12z in order to aid an operation of one-ehip ieroco-puter 2 ` .
The present invention is not li-ited for the easure-ent of blood glueose eoncentration and, for exanple, can be applied to a neasurenent of a cholesterol concentration or an alcohol concentration According to the Present invention as above described, there is Provided an econo~ic cethod and apparatus for easuring blood glucose concentration ::: , : :.
-. : ., ~ : ..... ~ : . ..
: ~ .: ,.... . . ..
,, ~, . . . -2~2~'26~
in a non-invasive technique, which can easily aeasure the blood d ucose concentration by putting port of the apParatus to a certain part of the hu an bodY sight of a blood ve~sel without using an equip ent, such as a conventional iniector.
,, . - .,: . . .
Claims (8)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A non-invasive method for measuring blood glucose concentration comprising the steps of;
supplying a power source from a battery to a processing means, a digital display, a laser diode power supply, a detector and an optical unit by means of a power switch;
controlling said processing means so that said laser diode power supply gradually applies current to said laser diode at a stable voltage and temperature by means of start/reset switch;
controlling said processing means so that a D/A converter coupled between said processing means and said laser diode power supply converts a digital control signal into an electrical control signal;
emitting a wavelength sufficient for measurement in said laser diode by means of said laser diode power supply;
callimating the light emitted from the laser diode parallel to a corresponding object, or optically controlling, separating and combining the light emitted from said laser diode;
irradiating through an integrating sphere said optically controlled light to a blood vessel to measure blood glucose concentration integrating by means of said integrating sphere the light absorbed, dispersed and diffusely reflected by the blood after the light reaches the skin to the blood;
transmitting the signal amplified by a preamplifier connected to said detector to an A/D converter, after converting photons integrated by said integrating sphere and detected by said detector into an electrical analog measurement value;
transmitting the signal to said processing means, after converting said electrical analog measurement value into a digital measurement value by means of said A/D converter;
calculating and computing blood glucose concentration by comparing a calibration curve stored in memory region of said processing means with a digital measurement value converted by said A/D converter;
displaying a calculated blood glucose concentration on said digital display.
supplying a power source from a battery to a processing means, a digital display, a laser diode power supply, a detector and an optical unit by means of a power switch;
controlling said processing means so that said laser diode power supply gradually applies current to said laser diode at a stable voltage and temperature by means of start/reset switch;
controlling said processing means so that a D/A converter coupled between said processing means and said laser diode power supply converts a digital control signal into an electrical control signal;
emitting a wavelength sufficient for measurement in said laser diode by means of said laser diode power supply;
callimating the light emitted from the laser diode parallel to a corresponding object, or optically controlling, separating and combining the light emitted from said laser diode;
irradiating through an integrating sphere said optically controlled light to a blood vessel to measure blood glucose concentration integrating by means of said integrating sphere the light absorbed, dispersed and diffusely reflected by the blood after the light reaches the skin to the blood;
transmitting the signal amplified by a preamplifier connected to said detector to an A/D converter, after converting photons integrated by said integrating sphere and detected by said detector into an electrical analog measurement value;
transmitting the signal to said processing means, after converting said electrical analog measurement value into a digital measurement value by means of said A/D converter;
calculating and computing blood glucose concentration by comparing a calibration curve stored in memory region of said processing means with a digital measurement value converted by said A/D converter;
displaying a calculated blood glucose concentration on said digital display.
2. A method for measuring blood glucose concentration according to claim 1, wherein said measurement method is based on physical and chemical principles of vibrational motion of blood glucose molecules is nesr-infrared radiation diffuse-reflection laser spectroscopy due to vibrational, rotational and translational motion, utilizing overtone vibrations and a combination of other types of vibrations.
3. A method for measuring blood glucose concentration according to claim 1, wherein in the step of calculating and computing blood glucose concentration by comparing a calibration curve stored in the memory of said processing means with a digital measurement value converted by said A/D converter, utilizes a mathematical method such as a multiple linear regression analysis and a multivariate analysis.
4. A non-invasive apparatus for measuring blood glucose concentration comprising;
processing means for controlling the flow of current supplied from a laser diode power supply to a laser diode so that current is applied gradually and at stable voltage and temperature levels, said processing means for calculating and computing blood glucose concentration by comparing and electrical analog measurement value detected and converted by a detector with a calibration curve stored in a memory of said processing means;
a D/A converter for controlling the laser diode power supply by converting a digital control signal to an analog control signal, wherein said laser diode power supply applies a power source to said laser diode as a light source for blood glucose concentration measurement, and said laser diode consisting of a plurality of diodes for emitting light of different wavelengths or emitting light of the sane wavelength, in accordance with the current supplied from said laser diode power supply;
a temperature controller which controls the temperature of said laser diode, said temperature controller being connected between said laser diode power supply and said laser diode;
an optical unit which collimates light emitted from said laser diode parallel to corresponding object and optically controls, separates or combines the light emitted from said laser diode;
an integrating sphere which integrates light dispersed and diffusely reflected from the blood by irradiating light controlled by said optical unit to the skin of a diabetics as a measurement part;
a detector which amplifies a signal by means of a preamplifier connected its own after converting photon integrated by said integrating sphere into an electrical analog measurement value; and an A/D convertor converts said electrical analog measurement value into a digital measurement value; and a digital display for displaying the calculated and computed blood glucose concentration
processing means for controlling the flow of current supplied from a laser diode power supply to a laser diode so that current is applied gradually and at stable voltage and temperature levels, said processing means for calculating and computing blood glucose concentration by comparing and electrical analog measurement value detected and converted by a detector with a calibration curve stored in a memory of said processing means;
a D/A converter for controlling the laser diode power supply by converting a digital control signal to an analog control signal, wherein said laser diode power supply applies a power source to said laser diode as a light source for blood glucose concentration measurement, and said laser diode consisting of a plurality of diodes for emitting light of different wavelengths or emitting light of the sane wavelength, in accordance with the current supplied from said laser diode power supply;
a temperature controller which controls the temperature of said laser diode, said temperature controller being connected between said laser diode power supply and said laser diode;
an optical unit which collimates light emitted from said laser diode parallel to corresponding object and optically controls, separates or combines the light emitted from said laser diode;
an integrating sphere which integrates light dispersed and diffusely reflected from the blood by irradiating light controlled by said optical unit to the skin of a diabetics as a measurement part;
a detector which amplifies a signal by means of a preamplifier connected its own after converting photon integrated by said integrating sphere into an electrical analog measurement value; and an A/D convertor converts said electrical analog measurement value into a digital measurement value; and a digital display for displaying the calculated and computed blood glucose concentration
5. An apparatus for measuring blood glucose concentration according to claim 4, wherein the wavelength of the electromagnetic radiation emitted from said laser diode is in the near-infrared region, and is 1.3 to 1.9µm among others, and more particularly, is 1.4 to 1.8µm, and the light emitted from said laser diode simultaneously irradiates the blood through the skin, or sequentially irradiates the blood through the skin.
8. An apparatus for measuring blood glucose concentration according to claim 4, wherein said integrating sphere is globular or like shape, oval or half oval or different shape, and said integrating sphere has a width, length and height under 2.56cm, and is suitable for under 1.28cm among others, and more particularly, is suitable for under 0.64cm, and said measurement apparatus has a width x length x height under 130mm x 70mm x20mm, and is suitable for under 150mm x 75mm x 22mm among others, and more particularly, is suitable for under 130mm x 70mm x 20mm.
7. In apparatus for measuring blood glucose concentration according to claim 4, wherein said port can be separated from the measurement apparatus by means of an optic fiber, and the distance between port and measurement apparatus is 100 ? 1,000mm, and is suitable for 500mm among others, and more particularly, is suitable for 300mm.
8. An apparatus for measuring blood glucose concentration according to claim 4, wherein a photo diode is utilized as said detector which detects photons integrated by said integrating sphere, and is utilized a Ge detector, and more particularly, is utilized a Ge detector coupled to a preamplifier, and said D/A converter and A/D converter are separated from said processing means, or are included in said processing means, and said battery used as a power source is 4.5 to 9V, and is suitable for a charging battery of 6V among others.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR89-15584 | 1989-10-28 | ||
| KR1019890015584A KR930011586B1 (en) | 1989-10-28 | 1989-10-28 | Non-invasive method and apparatus for measuring blood glucose concentration |
| KR90-11241 | 1990-07-24 | ||
| KR1019900011241A KR920002091A (en) | 1990-07-24 | 1990-07-24 | Egg-Invasive Blood Glucose Measurement Method and Apparatus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2028261A1 CA2028261A1 (en) | 1991-04-29 |
| CA2028261C true CA2028261C (en) | 1995-01-17 |
Family
ID=26628109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002028261A Expired - Fee Related CA2028261C (en) | 1989-10-28 | 1990-10-22 | Non-invasive method and apparatus for measuring blood glucose concentration |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5267152A (en) |
| EP (1) | EP0426358B1 (en) |
| JP (2) | JPH03146032A (en) |
| CN (1) | CN1025410C (en) |
| AT (1) | ATE179874T1 (en) |
| CA (1) | CA2028261C (en) |
| DE (1) | DE69033104T2 (en) |
| HU (1) | HU213438B (en) |
| RU (1) | RU2122208C1 (en) |
Families Citing this family (203)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204532A (en) * | 1989-01-19 | 1993-04-20 | Futrex, Inc. | Method for providing general calibration for near infrared instruments for measurement of blood glucose |
| US5237178A (en) * | 1990-06-27 | 1993-08-17 | Rosenthal Robert D | Non-invasive near-infrared quantitative measurement instrument |
| US6066847A (en) * | 1989-01-19 | 2000-05-23 | Futrex Inc. | Procedure for verifying the accuracy of non-invasive blood glucose measurement instruments |
| US5574283A (en) * | 1990-06-27 | 1996-11-12 | Futrex, Inc. | Non-invasive near-infrared quantitative measurement instrument |
| US5362966A (en) * | 1990-06-27 | 1994-11-08 | Rosenthal Robert D | Measurement of finger temperature in near-infrared quantitative measurement instrument |
| US5324979A (en) * | 1990-09-26 | 1994-06-28 | Futrex, Inc. | Method and means for generating synthetic spectra allowing quantitative measurement in near infrared measuring instruments |
| US5379774A (en) * | 1990-10-23 | 1995-01-10 | Sankyo Company Limited | Measurement of arterial elasticity and the frequency characteristic of the compliance of an artery |
| FR2679337B1 (en) * | 1991-07-17 | 1994-08-12 | Effets Biologiques Exercice | NON - INVASIVE PROCESS FOR IN VIVO DETERMINATION OF THE ARTERIAL BLOOD OXYGEN SATURATION RATE, AND DEVICE IMPLEMENTING THE METHOD. |
| JPH07508426A (en) * | 1991-10-17 | 1995-09-21 | サイエンティフィック ジェネリクス リミテッド | Blood sample measuring device and method |
| IL107396A (en) * | 1992-11-09 | 1997-02-18 | Boehringer Mannheim Gmbh | Method and apparatus for analytical determination of glucose in a biological matrix |
| US5447159A (en) * | 1993-02-03 | 1995-09-05 | Massachusetts Institute Of Technology | Optical imaging for specimens having dispersive properties |
| DE4337570A1 (en) * | 1993-11-04 | 1995-05-11 | Boehringer Mannheim Gmbh | Method for the analysis of glucose in a biological matrix |
| US5497769A (en) * | 1993-12-16 | 1996-03-12 | I.S.S. (Usa) Inc. | Photosensor with multiple light sources |
| US5492118A (en) * | 1993-12-16 | 1996-02-20 | Board Of Trustees Of The University Of Illinois | Determining material concentrations in tissues |
| US5529755A (en) * | 1994-02-22 | 1996-06-25 | Minolta Co., Ltd. | Apparatus for measuring a glucose concentration |
| TW275570B (en) * | 1994-05-05 | 1996-05-11 | Boehringer Mannheim Gmbh | |
| DE9417612U1 (en) * | 1994-11-03 | 1995-01-05 | Kloth Bernd | Sampling device |
| DE9418099U1 (en) * | 1994-11-15 | 1995-01-05 | Kloth Bernd | Analyzer |
| US5752512A (en) * | 1995-05-10 | 1998-05-19 | Massachusetts Institute Of Technology | Apparatus and method for non-invasive blood analyte measurement |
| SG38866A1 (en) * | 1995-07-31 | 1997-04-17 | Instrumentation Metrics Inc | Liquid correlation spectrometry |
| US6240306B1 (en) | 1995-08-09 | 2001-05-29 | Rio Grande Medical Technologies, Inc. | Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration |
| US6025597A (en) * | 1995-10-17 | 2000-02-15 | Optiscan Biomedical Corporation | Non-invasive infrared absorption spectrometer for measuring glucose or other constituents in a human or other body |
| US6040578A (en) * | 1996-02-02 | 2000-03-21 | Instrumentation Metrics, Inc. | Method and apparatus for multi-spectral analysis of organic blood analytes in noninvasive infrared spectroscopy |
| US5747806A (en) * | 1996-02-02 | 1998-05-05 | Instrumentation Metrics, Inc | Method and apparatus for multi-spectral analysis in noninvasive nir spectroscopy |
| US5666956A (en) * | 1996-05-20 | 1997-09-16 | Buchert; Janusz Michal | Instrument and method for non-invasive monitoring of human tissue analyte by measuring the body's infrared radiation |
| KR0165522B1 (en) * | 1996-05-23 | 1999-03-20 | 김광호 | Optimal point detector for non-invasive diagnosis of blood constituents and non-invasive diagnostic device using the same |
| US5903006A (en) * | 1996-05-31 | 1999-05-11 | Norihiro Kiuchi | Liquid concentration detecting apparatus |
| US5871442A (en) * | 1996-09-10 | 1999-02-16 | International Diagnostics Technologies, Inc. | Photonic molecular probe |
| US6594510B2 (en) | 1996-09-10 | 2003-07-15 | Xoetronics Llc | Photonic molecular probe |
| US5910109A (en) * | 1997-02-20 | 1999-06-08 | Emerging Technology Systems, Llc | Non-invasive glucose measuring device and method for measuring blood glucose |
| US5961451A (en) * | 1997-04-07 | 1999-10-05 | Motorola, Inc. | Noninvasive apparatus having a retaining member to retain a removable biosensor |
| US6628809B1 (en) | 1999-10-08 | 2003-09-30 | Lumidigm, Inc. | Apparatus and method for identification of individuals by near-infrared spectrum |
| US7890158B2 (en) | 2001-06-05 | 2011-02-15 | Lumidigm, Inc. | Apparatus and method of biometric determination using specialized optical spectroscopy systems |
| JP2002505008A (en) * | 1997-06-16 | 2002-02-12 | エラン コーポレーション ピーエルシー | Methods for calibrating and testing sensors for in vivo measurement of analytes and devices for use in such methods |
| US6043492A (en) * | 1997-10-27 | 2000-03-28 | Industrial Technology Research Institute | Non-invasive blood glucose meter |
| CA2265119C (en) | 1998-03-13 | 2002-12-03 | Cygnus, Inc. | Biosensor, iontophoretic sampling system, and methods of use thereof |
| US7875440B2 (en) | 1998-05-01 | 2011-01-25 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| US6780591B2 (en) | 1998-05-01 | 2004-08-24 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| US6097975A (en) * | 1998-05-13 | 2000-08-01 | Biosensor, Inc. | Apparatus and method for noninvasive glucose measurement |
| JP3507437B2 (en) | 1998-05-13 | 2004-03-15 | シグナス， インコーポレイテッド | Collection assembly for transdermal sampling systems |
| CA2332112C (en) | 1998-05-13 | 2004-02-10 | Cygnus, Inc. | Monitoring of physiological analytes |
| PT1077636E (en) | 1998-05-13 | 2004-06-30 | Cygnus Therapeutic Systems | SIGNAL PROCESSING FOR PHYSIOLOGICAL ANALYZES MEDICATION |
| WO1999058973A1 (en) | 1998-05-13 | 1999-11-18 | Cygnus, Inc. | Method and device for predicting physiological values |
| US6424851B1 (en) | 1998-10-13 | 2002-07-23 | Medoptix, Inc. | Infrared ATR glucose measurement system (II) |
| DE19923658A1 (en) * | 1999-05-22 | 2000-11-23 | Infralytic Gmbh | Device for measuring organization grade of water in mammals for diagnosis of disease conditions |
| US6818395B1 (en) | 1999-06-28 | 2004-11-16 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences |
| US6816605B2 (en) | 1999-10-08 | 2004-11-09 | Lumidigm, Inc. | Methods and systems for biometric identification of individuals using linear optical spectroscopy |
| US6361960B1 (en) | 1999-11-09 | 2002-03-26 | Environmentally Sensitive Solutions, Inc. | Method and test kit for measuring concentration of a cleaning agent in a wash liquor |
| DE19983992B4 (en) * | 1999-12-21 | 2009-07-23 | Valery Gennadevich Muzhikov | Method for determining blood characteristics |
| US7025425B2 (en) * | 2000-03-29 | 2006-04-11 | University Of Virginia Patent Foundation | Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data |
| US6549861B1 (en) | 2000-08-10 | 2003-04-15 | Euro-Celtique, S.A. | Automated system and method for spectroscopic analysis |
| EP1311189A4 (en) | 2000-08-21 | 2005-03-09 | Euro Celtique Sa | Near infrared blood glucose monitoring system |
| US6522903B1 (en) * | 2000-10-19 | 2003-02-18 | Medoptix, Inc. | Glucose measurement utilizing non-invasive assessment methods |
| WO2002072892A1 (en) | 2001-03-12 | 2002-09-19 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |
| US7126682B2 (en) | 2001-04-11 | 2006-10-24 | Rio Grande Medical Technologies, Inc. | Encoded variable filter spectrometer |
| US6983176B2 (en) | 2001-04-11 | 2006-01-03 | Rio Grande Medical Technologies, Inc. | Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopy |
| US6862091B2 (en) | 2001-04-11 | 2005-03-01 | Inlight Solutions, Inc. | Illumination device and method for spectroscopic analysis |
| US6574490B2 (en) | 2001-04-11 | 2003-06-03 | Rio Grande Medical Technologies, Inc. | System for non-invasive measurement of glucose in humans |
| US7043288B2 (en) | 2002-04-04 | 2006-05-09 | Inlight Solutions, Inc. | Apparatus and method for spectroscopic analysis of tissue to detect diabetes in an individual |
| US6865408B1 (en) | 2001-04-11 | 2005-03-08 | Inlight Solutions, Inc. | System for non-invasive measurement of glucose in humans |
| EP1271096A1 (en) * | 2001-06-18 | 2003-01-02 | Electronic Systems S.P.A. | Process and device for contactless measurement of the thickness of non-metallic films by using an infrared semiconductor emitter |
| US6989891B2 (en) | 2001-11-08 | 2006-01-24 | Optiscan Biomedical Corporation | Device and method for in vitro determination of analyte concentrations within body fluids |
| US20030235817A1 (en) * | 2002-03-22 | 2003-12-25 | Miroslaw Bartkowiak | Microprocessors, devices, and methods for use in analyte monitoring systems |
| US7027848B2 (en) | 2002-04-04 | 2006-04-11 | Inlight Solutions, Inc. | Apparatus and method for non-invasive spectroscopic measurement of analytes in tissue using a matched reference analyte |
| US6654125B2 (en) | 2002-04-04 | 2003-11-25 | Inlight Solutions, Inc | Method and apparatus for optical spectroscopy incorporating a vertical cavity surface emitting laser (VCSEL) as an interferometer reference |
| US8175666B2 (en) * | 2002-04-26 | 2012-05-08 | Grove Instruments, Inc. | Three diode optical bridge system |
| CA2495648C (en) | 2002-08-13 | 2014-07-22 | University Of Virginia Patent Foundation | Method, system, and computer program product for processing of self-monitoring blood glucose (smbg) data to enhance diabetic self-management |
| US7620212B1 (en) | 2002-08-13 | 2009-11-17 | Lumidigm, Inc. | Electro-optical sensor |
| US7233817B2 (en) * | 2002-11-01 | 2007-06-19 | Brian Yen | Apparatus and method for pattern delivery of radiation and biological characteristic analysis |
| CN100406872C (en) * | 2002-11-04 | 2008-07-30 | 天津市先石光学技术有限公司 | Composite spectral measurement method and its spectral detection instrument |
| CN1308740C (en) * | 2002-11-22 | 2007-04-04 | 天津市先石光学技术有限公司 | Method and apparatus for improving signal-to-noise ratio of acousto-optic tunable filter light splitting system |
| US7174198B2 (en) * | 2002-12-27 | 2007-02-06 | Igor Trofimov | Non-invasive detection of analytes in a complex matrix |
| WO2004060154A1 (en) * | 2003-01-07 | 2004-07-22 | Intelligent Photonics Control Corp. | Non-invasive blood monitor |
| KR20060002923A (en) | 2003-04-04 | 2006-01-09 | 루미다임 인크. | Multispectral biometric sensor |
| US7460696B2 (en) | 2004-06-01 | 2008-12-02 | Lumidigm, Inc. | Multispectral imaging biometrics |
| US7394919B2 (en) | 2004-06-01 | 2008-07-01 | Lumidigm, Inc. | Multispectral biometric imaging |
| US7751594B2 (en) | 2003-04-04 | 2010-07-06 | Lumidigm, Inc. | White-light spectral biometric sensors |
| US7627151B2 (en) | 2003-04-04 | 2009-12-01 | Lumidigm, Inc. | Systems and methods for improved biometric feature definition |
| US7347365B2 (en) | 2003-04-04 | 2008-03-25 | Lumidigm, Inc. | Combined total-internal-reflectance and tissue imaging systems and methods |
| US7545963B2 (en) | 2003-04-04 | 2009-06-09 | Lumidigm, Inc. | Texture-biometrics sensor |
| US7668350B2 (en) | 2003-04-04 | 2010-02-23 | Lumidigm, Inc. | Comparative texture analysis of tissue for biometric spoof detection |
| US7539330B2 (en) | 2004-06-01 | 2009-05-26 | Lumidigm, Inc. | Multispectral liveness determination |
| CN100427025C (en) * | 2003-04-10 | 2008-10-22 | 宇东科技股份有限公司 | Method for judging concentration of lood sugar |
| US7283242B2 (en) * | 2003-04-11 | 2007-10-16 | Thornton Robert L | Optical spectroscopy apparatus and method for measurement of analyte concentrations or other such species in a specimen employing a semiconductor laser-pumped, small-cavity fiber laser |
| US7633621B2 (en) * | 2003-04-11 | 2009-12-15 | Thornton Robert L | Method for measurement of analyte concentrations and semiconductor laser-pumped, small-cavity fiber lasers for such measurements and other applications |
| US6975892B2 (en) * | 2003-10-21 | 2005-12-13 | Oculir, Inc. | Methods for non-invasive analyte measurement from the conjunctiva |
| US6968222B2 (en) | 2003-05-02 | 2005-11-22 | Oculir, Inc. | Methods and device for non-invasive analyte measurement |
| US6958039B2 (en) | 2003-05-02 | 2005-10-25 | Oculir, Inc. | Method and instruments for non-invasive analyte measurement |
| US20040225206A1 (en) * | 2003-05-09 | 2004-11-11 | Kouchnir Mikhail A. | Non-invasive analyte measurement device having increased signal to noise ratios |
| US7356365B2 (en) * | 2003-07-09 | 2008-04-08 | Glucolight Corporation | Method and apparatus for tissue oximetry |
| WO2005018443A1 (en) | 2003-08-15 | 2005-03-03 | Animas Technologies Llc | Microprocessors, devices, and methods for use in monitoring of physiological analytes |
| US7169560B2 (en) * | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
| US7263213B2 (en) | 2003-12-11 | 2007-08-28 | Lumidigm, Inc. | Methods and systems for estimation of personal characteristics from biometric measurements |
| US20050137469A1 (en) * | 2003-12-17 | 2005-06-23 | Berman Herbert L. | Single detector infrared ATR glucose measurement system |
| US7510849B2 (en) * | 2004-01-29 | 2009-03-31 | Glucolight Corporation | OCT based method for diagnosis and therapy |
| JP3557425B1 (en) * | 2004-02-17 | 2004-08-25 | 株式会社日立製作所 | Blood glucose meter |
| JP3557424B1 (en) * | 2004-02-17 | 2004-08-25 | 株式会社日立製作所 | Blood glucose meter |
| WO2005080605A2 (en) | 2004-02-19 | 2005-09-01 | Helicos Biosciences Corporation | Methods and kits for analyzing polynucleotide sequences |
| JP3590053B1 (en) * | 2004-02-24 | 2004-11-17 | 株式会社日立製作所 | Blood glucose measurement device |
| JP3590054B1 (en) * | 2004-02-26 | 2004-11-17 | 株式会社日立製作所 | Blood glucose measurement device |
| US20050192492A1 (en) * | 2004-02-27 | 2005-09-01 | Ok-Kyung Cho | Blood sugar level measuring apparatus |
| AU2005220794A1 (en) * | 2004-03-06 | 2005-09-22 | Calisto Medical, Inc. | Methods and devices for non-invasively measuring quantitative information of substances in living organisms |
| DE602005027700D1 (en) | 2004-05-25 | 2011-06-09 | Helicos Biosciences Corp | PROCESS FOR NUCLEIC ACID IMMOBILIZATION |
| US7476734B2 (en) | 2005-12-06 | 2009-01-13 | Helicos Biosciences Corporation | Nucleotide analogs |
| US20110163163A1 (en) * | 2004-06-01 | 2011-07-07 | Lumidigm, Inc. | Multispectral barcode imaging |
| US7508965B2 (en) | 2004-06-01 | 2009-03-24 | Lumidigm, Inc. | System and method for robust fingerprint acquisition |
| US8229185B2 (en) | 2004-06-01 | 2012-07-24 | Lumidigm, Inc. | Hygienic biometric sensors |
| CN1297229C (en) * | 2004-07-27 | 2007-01-31 | 天津大学 | Non-invasive detection device of pulse impedance spectrum blood sugar or other biood component and its detection method |
| US8036727B2 (en) | 2004-08-11 | 2011-10-11 | Glt Acquisition Corp. | Methods for noninvasively measuring analyte levels in a subject |
| US8787630B2 (en) | 2004-08-11 | 2014-07-22 | Lumidigm, Inc. | Multispectral barcode imaging |
| US7254429B2 (en) * | 2004-08-11 | 2007-08-07 | Glucolight Corporation | Method and apparatus for monitoring glucose levels in a biological tissue |
| US20060253097A1 (en) * | 2004-10-21 | 2006-11-09 | Braig James R | Methods of treating diabetes |
| US7220549B2 (en) | 2004-12-30 | 2007-05-22 | Helicos Biosciences Corporation | Stabilizing a nucleic acid for nucleic acid sequencing |
| US7482120B2 (en) | 2005-01-28 | 2009-01-27 | Helicos Biosciences Corporation | Methods and compositions for improving fidelity in a nucleic acid synthesis reaction |
| WO2006110859A2 (en) | 2005-04-13 | 2006-10-19 | Glucolight Corporation | Method for data reduction and calibration of an oct-based blood glucose monitor |
| US7801338B2 (en) | 2005-04-27 | 2010-09-21 | Lumidigm, Inc. | Multispectral biometric sensors |
| US7409239B2 (en) * | 2005-05-05 | 2008-08-05 | The Hong Kong Polytechnic University | Method for predicting the blood glucose level of a person |
| JP2009502140A (en) | 2005-07-22 | 2009-01-29 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | Photoactivated cation channel and use thereof |
| US20090093403A1 (en) | 2007-03-01 | 2009-04-09 | Feng Zhang | Systems, methods and compositions for optical stimulation of target cells |
| US9274099B2 (en) | 2005-07-22 | 2016-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Screening test drugs to identify their effects on cell membrane voltage-gated ion channel |
| US10052497B2 (en) * | 2005-07-22 | 2018-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
| US9238150B2 (en) | 2005-07-22 | 2016-01-19 | The Board Of Trustees Of The Leland Stanford Junior University | Optical tissue interface method and apparatus for stimulating cells |
| US8926959B2 (en) * | 2005-07-22 | 2015-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
| US7666593B2 (en) | 2005-08-26 | 2010-02-23 | Helicos Biosciences Corporation | Single molecule sequencing of captured nucleic acids |
| CN100342825C (en) * | 2005-11-28 | 2007-10-17 | 何宗彦 | Non-wound rapid blood sugar detecting method and its detecting instrument |
| US20090305248A1 (en) * | 2005-12-15 | 2009-12-10 | Lander Eric G | Methods for increasing accuracy of nucleic acid sequencing |
| CA2636174C (en) | 2006-01-05 | 2022-07-05 | University Of Virginia Patent Foundation | Method, system and computer program product for evaluation of blood glucose variability in diabetes from self-monitoring data |
| US7397546B2 (en) | 2006-03-08 | 2008-07-08 | Helicos Biosciences Corporation | Systems and methods for reducing detected intensity non-uniformity in a laser beam |
| US8175346B2 (en) | 2006-07-19 | 2012-05-08 | Lumidigm, Inc. | Whole-hand multispectral biometric imaging |
| US7995808B2 (en) | 2006-07-19 | 2011-08-09 | Lumidigm, Inc. | Contactless multispectral biometric capture |
| CN101506826A (en) | 2006-07-19 | 2009-08-12 | 光谱辨识公司 | Multibiometric multispectral imager |
| US8355545B2 (en) | 2007-04-10 | 2013-01-15 | Lumidigm, Inc. | Biometric detection using spatial, temporal, and/or spectral techniques |
| US7804984B2 (en) | 2006-07-31 | 2010-09-28 | Lumidigm, Inc. | Spatial-spectral fingerprint spoof detection |
| US7801339B2 (en) | 2006-07-31 | 2010-09-21 | Lumidigm, Inc. | Biometrics with spatiospectral spoof detection |
| EP2063762A1 (en) * | 2006-09-06 | 2009-06-03 | Medingo Ltd. | Fluid delivery system with optical sensing of analyte concentration levels |
| DE202006021245U1 (en) | 2006-10-31 | 2014-03-28 | Valery Gennadievich Muzhikov | Device for the reflex correction of physical dysfunctions |
| DE112006003871T5 (en) | 2006-10-31 | 2009-03-19 | Valery Gennadievich Muzhiko | Method for the correction of the physical dysfunctions and device for carrying out the method |
| US20080154513A1 (en) | 2006-12-21 | 2008-06-26 | University Of Virginia Patent Foundation | Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes |
| WO2008086470A1 (en) | 2007-01-10 | 2008-07-17 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
| US8401609B2 (en) | 2007-02-14 | 2013-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | System, method and applications involving identification of biological circuits such as neurological characteristics |
| US8285010B2 (en) | 2007-03-21 | 2012-10-09 | Lumidigm, Inc. | Biometrics based on locally consistent features |
| US10035027B2 (en) | 2007-10-31 | 2018-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Device and method for ultrasonic neuromodulation via stereotactic frame based technique |
| US10434327B2 (en) | 2007-10-31 | 2019-10-08 | The Board Of Trustees Of The Leland Stanford Junior University | Implantable optical stimulators |
| DE102008006245A1 (en) * | 2008-01-25 | 2009-07-30 | Nirlus Engineering Ag | Method for the noninvasive, optical determination of the temperature of a medium |
| US8571617B2 (en) | 2008-03-04 | 2013-10-29 | Glt Acquisition Corp. | Flowometry in optical coherence tomography for analyte level estimation |
| US20110004080A1 (en) * | 2008-04-11 | 2011-01-06 | Glucovista, Llc | Method for non-invasive analysis of a substance concentration within a body |
| ES2608498T3 (en) | 2008-04-23 | 2017-04-11 | The Board Of Trustees Of The Leland Stanford Junior University | Systems, methods and compositions for optical stimulation of target cells |
| CN102036605A (en) * | 2008-05-19 | 2011-04-27 | 皇家飞利浦电子股份有限公司 | Perfusion regulation device |
| AU2009256457B2 (en) | 2008-05-29 | 2014-06-26 | The Board Of Trustees Of The Leland Stanford Junior University | Cell line, system and method for optical control of secondary messengers |
| CA2728402A1 (en) | 2008-06-17 | 2009-12-23 | The Board Of Trustees Of The Leland Stanford Junior University | Apparatus and methods for controlling cellular development |
| EP3192562B1 (en) | 2008-06-17 | 2020-03-04 | The Board of Trustees of the Leland Stanford Junior University | Devices for optical stimulation of target cells using an optical transmission element |
| WO2010006049A1 (en) | 2008-07-08 | 2010-01-14 | The Board Of Trustees Of The Leland Stanford Junior University | Materials and approaches for optical stimulation of the peripheral nervous system |
| NZ602416A (en) | 2008-11-14 | 2014-08-29 | Univ Leland Stanford Junior | Optically-based stimulation of target cells and modifications thereto |
| EP3703066A1 (en) | 2009-02-25 | 2020-09-02 | The University of Virginia Patent Foundation | Method, system and computer program product for cgm-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery |
| US7896498B2 (en) * | 2009-03-30 | 2011-03-01 | Ottawa Hospital Research Institute | Apparatus and method for optical measurements |
| WO2010138025A1 (en) | 2009-05-28 | 2010-12-02 | Muzhikov Valery Gennadievich | Device for the reflex correction of functional disorders of the body |
| US8872908B2 (en) | 2009-08-26 | 2014-10-28 | Lumidigm, Inc | Dual-imager biometric sensor |
| CN102018517A (en) * | 2009-09-17 | 2011-04-20 | 林紫谊 | Non-invasive glucometer |
| US8570149B2 (en) | 2010-03-16 | 2013-10-29 | Lumidigm, Inc. | Biometric imaging using an optical adaptive interface |
| SG183899A1 (en) | 2010-03-17 | 2012-10-30 | Univ Leland Stanford Junior | Light-sensitive ion-passing molecules |
| WO2012061681A1 (en) | 2010-11-05 | 2012-05-10 | The Board Of Trustees Of The Leland Stanford Junior University. | Control and characterization of memory function |
| CA2816971A1 (en) | 2010-11-05 | 2012-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Light-activated chimeric opsins and methods of using the same |
| JP6355335B2 (en) | 2010-11-05 | 2018-07-11 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | Optogenetic control of reward-related behavior |
| WO2012061690A2 (en) | 2010-11-05 | 2012-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Optically-controlled cns dysfunction |
| CA2816990A1 (en) | 2010-11-05 | 2012-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Stabilized step function opsin proteins and methods of using the same |
| CN110215614A (en) | 2010-11-05 | 2019-09-10 | 斯坦福大学托管董事会 | The upper conversion of light for light genetic method |
| US8696722B2 (en) | 2010-11-22 | 2014-04-15 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic magnetic resonance imaging |
| EP3524676A1 (en) | 2011-12-16 | 2019-08-14 | The Board of Trustees of The Leland Stanford Junior University | Opsin polypeptides and methods of use thereof |
| JP6537826B2 (en) | 2012-02-21 | 2019-07-03 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | Compositions and methods for treating pelvic floor neurological disorders |
| KR101487737B1 (en) * | 2012-03-21 | 2015-01-29 | 연세대학교 원주산학협력단 | Laser needle system for internal immaediate irradiating |
| US10660526B2 (en) | 2012-12-31 | 2020-05-26 | Omni Medsci, Inc. | Near-infrared time-of-flight imaging using laser diodes with Bragg reflectors |
| CA2895969A1 (en) | 2012-12-31 | 2014-07-03 | Omni Medsci, Inc. | Near-infrared lasers for non-invasive monitoring of glucose, ketones, hba1c, and other blood constituents |
| EP3184038B1 (en) | 2012-12-31 | 2019-02-20 | Omni MedSci, Inc. | Mouth guard with short-wave infrared super-continuum lasers for early detection of dental caries |
| US9500634B2 (en) | 2012-12-31 | 2016-11-22 | Omni Medsci, Inc. | Short-wave infrared super-continuum lasers for natural gas leak detection, exploration, and other active remote sensing applications |
| WO2014143276A2 (en) * | 2012-12-31 | 2014-09-18 | Omni Medsci, Inc. | Short-wave infrared super-continuum lasers for natural gas leak detection, exploration, and other active remote sensing applications |
| US9636380B2 (en) | 2013-03-15 | 2017-05-02 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic control of inputs to the ventral tegmental area |
| EP2968997B1 (en) | 2013-03-15 | 2019-06-26 | The Board of Trustees of the Leland Stanford Junior University | Optogenetic control of behavioral state |
| AU2014260101B2 (en) | 2013-04-29 | 2018-07-26 | Humboldt-Universitat Zu Berlin | Devices, systems and methods for optogenetic modulation of action potentials in target cells |
| WO2014179343A1 (en) | 2013-04-30 | 2014-11-06 | Abbott Diabetes Care Inc. | Systems, devices, and methods for energy efficient electrical device activation |
| AU2014306679A1 (en) | 2013-08-14 | 2016-03-10 | Circuit Therapeutics, Inc. | Compositions and methods for controlling pain |
| US10441201B2 (en) * | 2013-08-27 | 2019-10-15 | The Trustees Of Princeton Univerisity | Noninvasive mid-infrared in vivo glucose sensor |
| EP3013217B1 (en) * | 2014-01-07 | 2017-02-22 | Opsolution GmbH | Device and method for determining a concentration in a sample |
| US20160256088A1 (en) * | 2014-02-28 | 2016-09-08 | Tech4Life Enterprises Canada, Inc. | Device and mechanism for facilitating non-invasive, non-piercing monitoring of blood hemoglobin |
| CN104188664B (en) * | 2014-09-01 | 2016-03-30 | 苏州光环科技有限公司 | Blood sugar test scaling method and system |
| DK3197356T3 (en) | 2014-09-22 | 2021-02-01 | Dexcom Inc | MODE SWITCHING PROCEDURE |
| KR102390874B1 (en) | 2014-10-29 | 2022-04-26 | 삼성전자주식회사 | Glucose measure apparatus and method of measuring glucose thereof |
| CN104382605A (en) * | 2014-12-19 | 2015-03-04 | 新乡医学院 | Method for noninvasive and quick determination of blood glucose of rat |
| BR112017013630B1 (en) * | 2014-12-22 | 2022-10-04 | Artem Sergeevich Adzhemov | METHOD TO DETERMINE BLOOD GLUCOSE CONCENTRATION IN A NON-INVASIVE WAY |
| CN104950104B (en) * | 2015-06-12 | 2017-03-01 | 广州睿博医疗科技有限公司 | Four-in-one physiological parameter measuring device |
| WO2016209654A1 (en) | 2015-06-22 | 2016-12-29 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and devices for imaging and/or optogenetic control of light-responsive neurons |
| CN105342574A (en) * | 2015-12-11 | 2016-02-24 | 无限极（中国）有限公司 | Optical instrument for automatically searching myofascitis trigger point |
| CN106859666B (en) * | 2017-02-15 | 2018-12-04 | 舒糖讯息科技（深圳）有限公司 | A kind of blood sugar detection apparatus and its detection method |
| US11294165B2 (en) | 2017-03-30 | 2022-04-05 | The Board Of Trustees Of The Leland Stanford Junior University | Modular, electro-optical device for increasing the imaging field of view using time-sequential capture |
| CN107174258A (en) * | 2017-06-02 | 2017-09-19 | 北京信息科技大学 | Blood sugar concentration Forecasting Methodology |
| CN107505268A (en) * | 2017-08-04 | 2017-12-22 | 中国科学院半导体研究所 | Blood sugar detecting method and system |
| US11850440B2 (en) | 2019-08-22 | 2023-12-26 | University Of Iowa Research Foundation | Therapeutic systems using magnetic fields |
| US11071875B2 (en) | 2018-02-20 | 2021-07-27 | University Of Iowa Research Foundation | Therapeutic systems using magnetic and electric fields |
| US11089981B2 (en) | 2018-07-23 | 2021-08-17 | Samsung Electronics Co., Ltd. | Methods and systems for performing universal calibration to non-invasively determine blood glucose concentration |
| CN109846462B (en) * | 2019-04-03 | 2021-07-16 | 小甑科技（深圳）有限公司 | Method and system for measuring blood sugar |
| RU2718258C1 (en) * | 2019-07-02 | 2020-03-31 | Федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский государственный электротехнический университет "ЛЭТИ" им. В.И. Ульянова (Ленина)" (СПбГЭТУ "ЛЭТИ") | Method of non-invasive determination of blood glucose concentration |
| RU2746036C1 (en) | 2020-08-11 | 2021-04-06 | Валерий Геннадьевич Мужиков | Method for quantitative assessment of acupuncture channel activity, system and module for its implementation |
| CN112370607B (en) * | 2020-12-13 | 2022-08-05 | 李兴阳 | Insulin pump therapeutic instrument |
| DE102021004609A1 (en) | 2021-09-11 | 2023-03-16 | Eques Consulting GmbH | Device and method that can be carried out with it for the non-invasive determination of the concentration of components in the human bloodstream and use of the method. |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU146906A1 (en) * | 1961-07-14 | 1961-11-30 | В.А. Люхин | Photoplethysmography device |
| DE2606991A1 (en) * | 1976-02-20 | 1977-08-25 | Nils Dr Med Kaiser | DEVICE FOR DETERMINING THE CONTENT OF METABOLIC PRODUCTS IN THE BLOOD |
| JPS57124239A (en) * | 1981-01-26 | 1982-08-03 | Aloka Co Ltd | Biochemical component analysis apparatus by laser beam |
| ATE26485T1 (en) * | 1981-09-15 | 1987-04-15 | Mueller Arno | METHOD AND DEVICE FOR THE QUANTITATIVE DETERMINATION OF SOLUTES IN SINGLE AND MULTI-COMPONENT SYSTEMS BY LASER LIGHT SCATTERING. |
| DE3328862A1 (en) * | 1982-09-16 | 1985-02-28 | Siemens AG, 1000 Berlin und 8000 München | Tissue photometry method and device, in particular for quantatively determining the blood oxygen saturation from photometric measurements |
| US4679562A (en) * | 1983-02-16 | 1987-07-14 | Cardiac Pacemakers, Inc. | Glucose sensor |
| JPH0737946B2 (en) * | 1983-08-05 | 1995-04-26 | 株式会社京都第一科学 | A device that measures body fluid components and stores and manages test data |
| JPS6075032A (en) * | 1983-09-30 | 1985-04-27 | アロカ株式会社 | Biochemical component analyser due to laser beam |
| US4570638A (en) * | 1983-10-14 | 1986-02-18 | Somanetics Corporation | Method and apparatus for spectral transmissibility examination and analysis |
| ATE42673T1 (en) * | 1984-05-04 | 1989-05-15 | Kurashiki Boseki Kk | SPECTROPHOTOMETRIC DEVICE FOR THE BLOOD-FREE DETERMINATION OF GLUCOSE IN LIVING TISSUE. |
| US4655225A (en) * | 1985-04-18 | 1987-04-07 | Kurabo Industries Ltd. | Spectrophotometric method and apparatus for the non-invasive |
| US4685463A (en) * | 1986-04-03 | 1987-08-11 | Williams R Bruce | Device for continuous in vivo measurement of blood glucose concentrations |
| US4759369A (en) * | 1986-07-07 | 1988-07-26 | Novametrix Medical Systems, Inc. | Pulse oximeter |
| US4913150A (en) * | 1986-08-18 | 1990-04-03 | Physio-Control Corporation | Method and apparatus for the automatic calibration of signals employed in oximetry |
| US4714080A (en) * | 1986-10-06 | 1987-12-22 | Nippon Colin Co., Ltd. | Method and apparatus for noninvasive monitoring of arterial blood oxygen saturation |
| GB8700061D0 (en) * | 1987-01-05 | 1987-02-11 | Whatman Reeve Angel Plc | Light absorption analyser |
| JPH0827235B2 (en) * | 1987-11-17 | 1996-03-21 | 倉敷紡績株式会社 | Spectroscopic method for measuring sugar concentration |
| US4800885A (en) * | 1987-12-02 | 1989-01-31 | The Boc Group, Inc. | Blood constituent monitoring apparatus and methods with frequency division multiplexing |
| US4882492A (en) * | 1988-01-19 | 1989-11-21 | Biotronics Associates, Inc. | Non-invasive near infrared measurement of blood analyte concentrations |
| US5077476A (en) * | 1990-06-27 | 1991-12-31 | Futrex, Inc. | Instrument for non-invasive measurement of blood glucose |
| US5028787A (en) * | 1989-01-19 | 1991-07-02 | Futrex, Inc. | Non-invasive measurement of blood glucose |
| US5187368A (en) * | 1989-09-29 | 1993-02-16 | Glaxo Inc. | Detection method for liquids using near infrared spectra |
| US4977591A (en) * | 1989-11-17 | 1990-12-11 | Nynex Corporation | Dual mode LMS nonlinear data echo canceller |
| US5070874A (en) * | 1990-01-30 | 1991-12-10 | Biocontrol Technology, Inc. | Non-invasive determination of glucose concentration in body of patients |
| US5054487A (en) * | 1990-02-02 | 1991-10-08 | Boston Advanced Technologies, Inc. | Laser systems for material analysis based on reflectance ratio detection |
-
1990
- 1990-10-22 CA CA002028261A patent/CA2028261C/en not_active Expired - Fee Related
- 1990-10-23 DE DE1990633104 patent/DE69033104T2/en not_active Expired - Fee Related
- 1990-10-23 AT AT90311596T patent/ATE179874T1/en not_active IP Right Cessation
- 1990-10-23 EP EP19900311596 patent/EP0426358B1/en not_active Expired - Lifetime
- 1990-10-24 JP JP2286941A patent/JPH03146032A/en active Granted
- 1990-10-26 HU HU906914A patent/HU213438B/en not_active IP Right Cessation
- 1990-10-26 US US07/604,800 patent/US5267152A/en not_active Expired - Lifetime
- 1990-10-26 RU SU4831608A patent/RU2122208C1/en not_active IP Right Cessation
- 1990-10-27 CN CN90108775A patent/CN1025410C/en not_active Expired - Fee Related
-
1997
- 1997-08-18 JP JP1997007317U patent/JP2588468Y2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69033104T2 (en) | 1999-10-28 |
| JPH0581253B2 (en) | 1993-11-12 |
| EP0426358B1 (en) | 1999-05-12 |
| RU2122208C1 (en) | 1998-11-20 |
| HU906914D0 (en) | 1991-05-28 |
| CA2028261A1 (en) | 1991-04-29 |
| CN1025410C (en) | 1994-07-13 |
| JP2588468Y2 (en) | 1999-01-13 |
| CN1051297A (en) | 1991-05-15 |
| EP0426358A1 (en) | 1991-05-08 |
| JPH10181U (en) | 1998-08-25 |
| HU213438B (en) | 1997-06-30 |
| JPH03146032A (en) | 1991-06-21 |
| ATE179874T1 (en) | 1999-05-15 |
| DE69033104D1 (en) | 1999-06-17 |
| HUT58145A (en) | 1992-01-28 |
| US5267152A (en) | 1993-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2028261C (en) | Non-invasive method and apparatus for measuring blood glucose concentration | |
| JP3875798B2 (en) | Method of operating a bloodless measuring device for blood component concentration and bloodless measuring device | |
| US5365066A (en) | Low cost means for increasing measurement sensitivity in LED/IRED near-infrared instruments | |
| US5703364A (en) | Method and apparatus for near-infrared quantitative analysis | |
| US7389131B2 (en) | Living body information measuring apparatus | |
| US6097975A (en) | Apparatus and method for noninvasive glucose measurement | |
| US6304767B1 (en) | Non-invasive optical measurement of blood hematocrit | |
| EP0623306A1 (en) | Method for non-invasive measurement of concentration of analytes in blood using continuous spectrum radiation | |
| CN101467884B (en) | Non-invasive method and device for rapidly detecting blood sugar | |
| US10278622B2 (en) | Device for non-invasive measurement of blood sugar level | |
| GB2162939A (en) | A multiple wavelength light photometer for non-invasive monitoring | |
| CN1032587A (en) | Optoacoustic spectroscopy | |
| CA2131715A1 (en) | Blood chemistry measurement by stimulated infrared emission | |
| US20130267799A1 (en) | Noninvasive measurement of analyte concentration using a fiberless transflectance probe | |
| KR100300960B1 (en) | Method and device for noninvasive determination of the concentrations of blood components | |
| JPS6157774B2 (en) | ||
| KR930011586B1 (en) | Non-invasive method and apparatus for measuring blood glucose concentration | |
| US20130267798A1 (en) | Noninvasive measurement of analyte concentration using a fiberless transflectance probe | |
| JPH09178657A (en) | Noninvasive biochemical measuring apparatus | |
| KR920002091A (en) | Egg-Invasive Blood Glucose Measurement Method and Apparatus | |
| KR920002092A (en) | Egg-Invasive Blood Glucose Measurement Method and Apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |